ストックスクリーナーアプリを入手
0.595
10.02%
0.0542
前日終値:
$0.5408
開ける：
$0.54
24時間の取引高:
275.09K
Relative Volume:
1.04
時価総額：
$46.85M
収益：
$9.53M
当期純損益:
$-44.61M
株価収益率:
-0.6538
EPS:
-0.91
ネットキャッシュフロー:
$-38.32M
1週間 パフォーマンス:
-5.56%
1か月 パフォーマンス:
-27.88%
6か月 パフォーマンス:
-1.03%
1年 パフォーマンス:
-42.23%
1日の値動き範囲:
$0.54
$0.6098
1週間の範囲:
$0.54
$0.6436
52週間の値動き範囲:
$0.54
$1.75
Cue Biopharma Inc Stock (CUE) Company Profile
CUE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.595 | 42.58M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-13 | 開始されました | Jefferies | Buy |
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2022-11-21 | 開始されました | Piper Sandler | Overweight |
| 2022-01-13 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-03 | 開始されました | Craig Hallum | Buy |
| 2020-11-24 | 開始されました | Berenberg | Buy |
| 2020-04-09 | 開始されました | Stifel | Buy |
| 2020-01-28 | 開始されました | BTIG Research | Buy |
| 2020-01-22 | 開始されました | JMP Securities | Mkt Outperform |
すべてを表示
Cue Biopharma Inc (CUE) 最新ニュース
Can Cue Biopharma Inc. stock resist market sell offsGlobal Markets & Smart Swing Trading Alerts - newser.com
Will Cue Biopharma Inc. stock recover faster than peers2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Is Cue Biopharma Inc. stock dividend yield sustainableWeekly Trade Report & Verified Chart Pattern Signals - newser.com
Cue Biopharma Announces CMO Departure - TipRanks
Cue Biopharma Announces Departure of Chief Medical Officer - TradingView
[8-K] Cue Biopharma, Inc. Reports Material Event | CUE SEC FilingForm 8-K - Stock Titan
Why Cue Biopharma Inc. (1UC) stock benefits from AI revolutionEarnings Beat & Reliable Trade Execution Plans - newser.com
Is Cue Biopharma Inc. stock trading at a premium valuationPortfolio Risk Report & Risk Adjusted Buy/Sell Alerts - newser.com
Will Cue Biopharma Inc. (1UC) stock deliver compounding returns2025 Market WrapUp & Risk Controlled Daily Plans - newser.com
Why Cue Biopharma Inc. (1UC) stock could be next leader2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com
How Cue Biopharma Inc. stock performs in rate cut cycles2025 Geopolitical Influence & Advanced Swing Trade Entry Plans - newser.com
Can Cue Biopharma Inc. (1UC) stock expand revenue streams2025 Market Overview & Smart Investment Allocation Insights - newser.com
What dividend safety score for Cue Biopharma Inc. stockJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com
Is Cue Biopharma Inc. stock gaining market shareWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Is Cue Biopharma Inc. stock attractive for hedge fundsBond Market & Fast Entry Momentum Trade Alerts - newser.com
Trend analysis for Cue Biopharma Inc. this week2025 Market WrapUp & Safe Capital Allocation Plans - newser.com
Is Cue Biopharma Inc. stock resilient to inflationWeekly Stock Analysis & Daily Entry Point Trade Alerts - newser.com
Cue Biopharma stock rating reiterated at Market Outperform by Citizens - Investing.com Canada
How supply chain issues affect Cue Biopharma Inc. stockJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - newser.com
Singapore's ImmunoScape partners with Cue Biopharma to advance solid-tumour cell therapy - BioSpectrum Asia
Risk adjusted return profile for Cue Biopharma Inc. analyzedPortfolio Value Summary & Low Risk Entry Point Tips - newser.com
Cue Biopharma Inc (CUE) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):